News & Events about Hologic Inc.
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2023 on Monday, July 31, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time...
Hologic, Inc. (NASDAQ:HOLX Get Rating) Director Scott T. Garrett sold 10,000 shares of the companys stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $79.72, for a total value of $797,200.00. Following the completion of the transaction, the ...
StockNews.com downgraded shares of Hologic (NASDAQ:HOLX Get Rating) from a buy rating to a hold rating in a research report released on Wednesday morning. HOLX has been the subject of several other reports. JPMorgan Chase & Co. upped their price target on shares of Hologic from $90.00 to $95.00 and ...
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire VANCOUVER, British Columbia, March 24, 2023 FN Media Group Presents USA News Group News Commentary VANCOUVER...